Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults

NCT05547438 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: NTS-104 TRIS
DRUG: Placebo

Sponsor

NeuroTrauma Sciences, LLC

Collaborators

[object Object]